Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Microbyre

Explore full profile

Domestication and genetic engineering of non-model bacteria for industrial applications

Berkeley, United StatesFounded 2017Health
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Microbyre and the history behind them.

About Microbyre

MicroByre operates within the biotechnology sector, focusing on the domestication and genetic engineering of non-model bacteria for industrial applications. Founded in 2017 by Sarah Richardson, Jeff Anderson, and Margaret Brown, the Berkeley-based company aims to displace petrochemical-based manufacturing by providing biological alternatives.

The company's core technology is a platform that identifies and cultivates naturally occurring bacteria, which are typically considered difficult to grow and genetically modify. This process, which they term "domestication," involves creating genomic toolkits and using machine learning and robotics to pinpoint bacteria that meet specific industrial criteria. MicroByre then applies minimal genetic modifications to enhance their capabilities. This approach allows for the development of microbes that can convert unused biomass and waste products into valuable chemicals, enzymes, and other commodities. As of June 2023, the company stated its computational platform could engineer these microbes at a cost ten times lower than the industry average.

The founding team's expertise is central to the company's strategy. CEO Sarah Richardson holds a Ph.D. in Human Genetics and Molecular Biology from Johns Hopkins University and was a Distinguished Postdoctoral Fellow in Genomics at Lawrence Berkeley National Laboratory. Her extensive background in computational and molecular biology, particularly in genome design and synthetic biology, directly informs MicroByre's scientific direction. Co-founder Jeff Anderson serves as President.

MicroByre's business model appears to be centered on licensing its proprietary, engineered bacterial strains to companies in various sectors for use in fermentation processes. These clients can then produce bio-derived chemistries more economically and sustainably than through traditional petrochemical methods. The key benefits offered to clients include the ability to utilize cheaper feedstocks like agricultural waste, potentially reduce nutritional additives, and improve resistance to contamination. By focusing on bacteria that naturally consume waste, MicroByre provides a more profitable and environmentally friendly manufacturing alternative. The company has secured significant venture capital, raising a total of $20.5M, including a $15M Series A round in January 2022 led by Lowercarbon Capital. However, some sources from mid-2024 indicate the company may no longer be active.

Source: Dealroom company data

At a glance

Founded
2017
Headquarters
Berkeley, United States
Sector
Health

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Earthshot Ventures
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Microbyre on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Microbyre on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.